VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy

NCT00004216 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: salmonella VNP20009
DRUG: cefixime
DRUG: ceftriaxone sodium
DRUG: ciprofloxacin
DRUG: trimethoprim-sulfamethoxazole

Sponsor

Vion Pharmaceuticals